Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
53%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
PBPH
57
HOLDINGS
24%
ALSO IN MEDX
MEDX
27
HOLDINGS
44%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.9% | 21.2% | 16.9% |
|
ABBVIE INC | 7.4% | 10.1% | 7.4% |
|
JOHNSON & JOHNSON | 9.3% | 5.8% | 5.8% |
 |
ASTRAZENECA PLC | 4.8% | 4.8% | 4.8% |
|
MERCK & CO. INC. | 5.2% | 4.5% | 4.5% |
PBPH Overweight Relative to MEDX
 |
NOVARTIS AG | 4.2% |
|
GILEAD SCIENCES INC | 4.1% |
|
JOHNSON & JOHNSON | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
 |
NOVO NORDISK A/S-B | 2.5% |
 |
SANOFI-AVENTIS | 1.9% |
|
GSK PLC | 1.8% |
|
MODERNA, INC. | 1.5% |
 |
CSL LIMITED | 1.3% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 1.3% |
PBPH Underweight Relative to MEDX
|
NOVARTIS AG-ADR | -6.9% |
 |
ALKERMES PLC | -4.6% |
|
ELI LILLY & CO | -4.3% |
|
BIOGEN IDEC INC | -2.8% |
|
ABBVIE INC | -2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.5% |
|
CRISPR THERAPEUTICS AG | -2.4% |
|
IONIS PHARMACEUTICALS, INC. | -2.4% |
|
BRISTOL-MYERS SQUIBB CO | -1.7% |
|
ALNYLAM PHARMACEUTICALS INC | -1.4% |